Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer

Cancer

Volumn 115, Issue 22, 2009, Pages 5309-5318

  Meng, Zhiqiang ^b   Yang, Peiying ^a   Shen, Yehua ^b   Bei, Wenying ^b   Zhang, Ying ^b   Ge, Yongqian ^b   Newman, Robert A ^a,c   Cohen, Lorenzo ^a   Liu, Luming ^b   Thornton, Bob ^a,d   Chang, David Z ^a   Liao, Zongxing ^a   Kurzrock, Razelle ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^c New Chapter Inc   (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Hepatocellular cancer; Nonsmall cell lung cancer; Pancreatic cancer; Phase 1; Traditional Chinese medicine

Indexed keywords

BUFALIN; CHINESE DRUG; HUACHANSU; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AGED; ANOREXIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER REGRESSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DOSE ESCALATION; DRUG ERUPTION; DYSPNEA; FEMALE; HEART VENTRICLE EXTRASYSTOLE; HUMAN; HYPERTENSION; LEUKOPENIA; LIVER CELL CARCINOMA; LUNG NON SMALL CELL CANCER; MALE; MOUTH ULCER; MULTIPLE CYCLE TREATMENT; MYALGIA; PANCREAS CANCER; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; THROMBOCYTOPENIA; TREATMENT RESPONSE;

AGED; AMPHIBIAN VENOMS; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MEDICINE, CHINESE TRADITIONAL; MIDDLE AGED; PANCREATIC NEOPLASMS; PILOT PROJECTS;

EID: 70449376872     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24602     Document Type: Article

References (29)

1. Huang KC. Anesthetic and muscle-relaxing herbs: chan su. In: The Pharmacology of Chinese Herbs. Boca Raton, FL: CRC Press; 1993:114-115.
2. Yan ZH, Weng WJ, Gao XM, et al. Chan su. Chin Mater Med. 1979:425.
3. Su YH, Nu X. Evaluation of pharmacodynamic effect of pharmaceutical agents of Chan Su. J Beijing Univ TCM. 2001;24:51-54.
4. Su YH, Huang XQ, Zhang DZ, Zhang YN, Xie JM, Linh CQ. HPLC separation and determination of bufadienolide in cinobufacini injection. Chin Tradit Pat Med. 2003;25:24-27.
5. Newman RA, Yang P, Pawlus AD, Block KI. Cardiac glycosides as novel cancer therapeutic agents. Mol Interv. 2008; 8:36-49.
6. Hang L. Clinical effect of HuaChanSu injection in combination with chemotherapy in advanced lung cancer. Henan J Oncol. 2002;15:70.
7. Zhongjie S, Chengen P, Guojun W. Clinical observation on HuaChanSu in treating hepatocellular carcinoma after transarterial chemoembolization (TACE). Cancer Prevent and Treat. 2002;29:67-69.
8. Suxia H, Qing Z, Dongxiu L. Clinical effect of Hua- ChanSu combined with radiotherapy in cancer treatment. Shanxi J Med. 2002;31:60-61.
9. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000;92:205-216.
10. Cleeland CS, Mendoza TR, Wang XS, et al. Assessing symptom distress in cancer: The M. D. Anderson Symptom Inventory. Cancer. 2000;89:1634-1646.
11. Haas M, Askari A, Xie Z. Involvement of Src and epidermal growth factor receptor in the signal-transduction function of Na+/K+-ATPase. J Biol Chem. 2000;275:27832-27837. (Pubitemid 30688898)
12. Kamano Y, Nogawa T, Yamashita A, Hayashi M, Inoue M. Isolation and structure of a 20,21-epoxybufenolide series from "Ch'an Su". J Nat Prod. 2002;65:1001-1005.
13. Masuda Y, Kawazoe N, Nakajo S, Yoshida T, Kuroiwa Y, Nakaya K. Bufalin induces apoptosis and influences the expression of apoptosis-related genes in human leukemia cells. Leuk Res. 1995;19:549-556.
14. Zhang L, Wang Q, Lu w, Zhang X, Zheng J, Wang Q. Chemotherapeutic effect of Huachansu on human lung cancer: 106 case report. Chin J Clin Oncol Rehabil. 2001;8:90-91.
15. Haux J, Solheim O, Isaksen T, Angelsen A. Digitoxin, non-toxic concentrations, inhibits proliferation and induces cell death in prostate cancer cell lines. Z Onkol. 2000;32:14-20. (Pubitemid 30214332)
16. Huang YT, Chuedh SC, Teng CM, Guh JH. Investigation of ouabain-induced anticancer effect in human androgenindependent prostate cancer PC-3 cells. Biochem Pharmacol. 2004;67:727-733. (Pubitemid 38125256)
17. Jing Y, Ohizumi H, Kawazoe N, et al. Selective inhibitory effect of bufalin on growth of human tumor cells in vitro: association with the induction of apoptosis in leukemia HL-60 cells. Jpn J Cancer Res. 1994;85:645-651. (Pubitemid 24191241)
18. Johansson S, Lindholm P, Gullbo J, Larsson R, Bohlin L, Claeson P. Cytotoxicity of digitoxin and related cardiac glycosides in human tumor cells. Anticancer Drugs. 2001;12:475-483. (Pubitemid 32643092)
19. Kawazoe N, Watabe M, Masuda Y, Nakajo S, Nakaya K. Tiam1 is involved in the regulation of bufalin-induced apoptosis in human leukemia cells. Oncogene. 1999;18:2413-2421. (Pubitemid 29206154)
20. Mckonkey DJ, Lin Y, Nutt LK, Ozel HZ, Newman RA. Cardiac glycosides stimulate Ca2+ increases and apoptosis in androgen-independent, metastatic human prostate adenocarcinoma cells. Cancer Res. 2000;60:3807-3812. (Pubitemid 32204572)
21. Yeh JY, Huang WJSFK, Wang PS. Effects of bufalin and cinobufalin on the proliferation of androgen dependent and independent prostate cancer cells. Prostate. 2003;54:112-124.
22. Hashimoto S, Jing Y, Kawazoe N. Bufalin reduces the level of topoisomerase II in human leukemia cells and affects the cytotoxicity of anticancer drugs. Leuk Res. 1997;21:875-883. (Pubitemid 27488715)
23. Xie ZJ, Cai T. Na+-K+-ATPase mediated signal transudation: from protein interaction to cellular function. Mol Interv. 2003;3:157-168.
24. Chen GH. Advances in quality determination, pharmacological studies and clinical application of toad venom. Chin Tradit Herb Drugs. 2001;32:184-186.
25. Cuo XD, Cuei YA, Wang JH, Qin S, Chen HY. The effect of cinobufacini on human gastric neoplasm cell line MGC-80-3. Chin Clin Oncol. 2003;8:33-37.
26. Zhang ZY, Zhang KH, Wang ZW, Zhu JQ, Zhu ZH, Huang DQ. Cytotoxicity of HuaChanSu on 3 digestive tract tumor cells in vitro. Chin Med Pharm Clin. 1999;15:28-29.
27. Cuo XD, Cuei YA, Qin S, Chen HY, Wang JH. Effect of cinobufacini on tumor cell cycle and expression of bcl-2 protein. Mod J Integr Tradit Chin West Med. 2003;12:567-568.
28. Guan J, Zhao XH, Jiang BS, Chen ZW, Qin QY. Preliminary study on the antitumor mechanism of cinobufacini injection. J Penfu Med Coll. 1993;18:78-81.
29. Lin Y, Fu J, Chen XW, Lin DQ. Experimental study on anticancer action of cinobufacini injection for pulmonary carcinoma. J Guangzhou Univ Tradit Chin Med. 2003;20:69-71.